Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Ameritek Ventures, Inc.

CIK: 15301852 Annual ReportsLatest: 2025-05-12

10-K / May 12, 2025

Revenue:$678,300
Income:$4,496,799

10-K / April 1, 2024

Revenue:$949,438
Income:-$58,910

10-K / May 12, 2025

Company Overview: Ameritek Ventures, Inc.

Business Operations and Focus

  • Legal Formation & Name Change:
    Organized on December 27, 2010, in Nevada as ATVROCKN; renamed Ameritek Ventures, Inc on June 20, 2017.

  • Core Business Lines:

    1. Software and Hardware Products & Services:
      • Provides solutions for businesses, organizations, and governments.
    2. Warehouse Solutions Market:
      • Software inventory management through Interactive Systems, Inc.
      • SaaS cloud-based solutions for warehouse and inventory fulfillment via interlinkONE, Inc.
    3. Medical Industry Innovation:
      • Develops advanced medical products such as DittoMask, a high-filtration mask.
    4. Blockchain Technology Software:
      • Develops blockchain applications under WebBeeO and CordTell.
    5. Augmented Reality Technology:
      • Explores AR with Augmum, Inc..
    6. Aerospace & Transportation:
      • Offers vertical landing aircraft services through AeroPass, Inc. using ZenaDrone technology, focusing on first-class city-to-city passenger transport.
    7. ** mergers & acquisitions:**
      • Ecker Capital, LLC handles M&A activities. Sold this division to ZenaTech, Inc. effective October 1, 2024.
    8. Business Strategy Software:
      • ESM Software, Inc. develops business management solutions.
    9. Electric Bicycles:
      • Recently created Equock, Inc. to develop electric bicycles targeting the online delivery sector.
  • Recent Corporate Activity:

    • Sold Ecker Capital, LLC on October 1, 2024, to ZenaTech (related party).
    • Currently revenue mainly from DittoMask; no profit was generated from DittoMask in 2024.

Financial Data (as of December 31, 2024)

  • Revenue:

    • $678,300 for the year 2024 (a decrease from $949,438 in 2023, due to the sale of Interactive Systems and interlinkONE).
  • Net Income:

    • $4,496,799 in 2024 (a significant turnaround from a net loss of $58,910 in 2023).
    • The large profit in 2024 is primarily due to gains from the sale of assets (notably Ecker Capital sale to ZenaTech).
  • Expenses:

    • Operating expenses decreased significantly (44%) after divestitures, with development/support expenses down 43% and general/admin expenses down 41%.
    • Depreciation and amortization decreased by 61%.
  • Assets & Liabilities:

    • Total assets as of December 31, 2024: $7,185,283.
    • Total liabilities: $2,477,586 (decrease from prior year).
    • Cash as of December 31, 2024: $0 (down from $5,618 in 2023) due to asset sales.
  • Customer & Shareholder Data:

    • Outstanding shares: approximately 613 million common shares as of December 31, 2024.
    • Shareholders: about 110 record holders.

Employees & Customers

  • The filings do not specify the number of employees or detailed customer counts.

Key Notes

  • The company’s operations have largely shifted from revenue-generating activities (like software and M&A divisions) to asset sales, primarily reflected in the notable profit from asset disposal.
  • The company’s revenue streams, profit, and operations are heavily influenced by the sale of divisions and assets, with no ongoing profit from core product lines as of the latest filing.
  • The company is closely related to Epazz, Inc., and other affiliated entities, with significant stockholdings by Shaun Passley, PhD, and family members.

Summary:
Ameritek Ventures, Inc. is a diversified technology company with interests spanning software solutions for enterprise warehouse and inventory management, medical products (notably DittoMask), blockchain tech, augmented reality, aerospace transportation services, and electric bicycles. Its 2024 financials show a pivot toward asset sales yielding significant profits, with no current revenue from core product operations. The company is publicly traded on OTC Pink Sheets with approximately 613 million common shares outstanding and no reported employees or specific customer counts in the filed reports.